Recent from talks
Nothing was collected or created yet.
Bona Film Group
View on WikipediaBona Film Group Company Limited (simplified Chinese: 博纳影业集团有限公司; traditional Chinese: 博納影业集團有限公司, formerly known as Beijing Polybona Film Distribution Co. Ltd. (保利博纳电影发行有限公司) ), also known as Polybona Films or the Bona Film Group, is a Chinese production company and distributor of films from mainland China and Hong Kong. It is run as a subsidiary of the China Poly Group, and is one of China's largest share-holding film distribution companies.
Key Information
It was named "the Chinese Miramax" by Screen International in 2005, and its CEO, Yu Dong, was described as one of "the future’s most influential filmmakers" by The Hollywood Reporter in November 2006.[1][2]
History
[edit]Founded in 1999, Polybona was the first domestic private firm to receive a film distribution license from the SARFT. In November 2003, it merged with the China Poly Group, a wealthy business conglomerate wing of the Chinese military, the People's Liberation Army, to form PolyBona Film Distribution.[3]
The company has distributed over 120 domestic and foreign films, including Confession of Pain, Protégé, The Myth, Initial D, and Dragon Tiger Gate, generating over RMB 1 billion (approximately US$130 million) in box office revenue, capturing over 20% of the overall market share for five years running.
It has also co-produced over 20 feature films, including The Warlords, Red Cliff, Flash Point, and After This Our Exile.
In 2007, Variety recognized the successful growth of Polybona Films, and wrote highly about its transforming from Miramax to Paramount.
In 2014, the company had a 10% share of the Chinese box office, earning CN¥3 billion from 12 films released.[4]
In 2014, the company was the fourth-largest film distributor in China, with 5.99% of the market.[5]
As of April 2015, the company was worth US$542 million.[6]
In Q1 of 2015, it had a gross profit of US$45 million, a revenue of US$117.6 million, and a box office gross of US$257 million.[7]
In November 2015, it was reported that Bona invested US$235 million in TSG Entertainment, resulting in a stake in six films distributed by 20th Century Fox, including The Martian (2015).[8]
In 2016, the company had a market share of 9%, with a gross of CN¥3.7 billion (US$532.2 million).[9]
Filmography
[edit]Released
[edit]| Year | Title | Director | Co-production company(s) | Distributor(s) | Box office | Ref. |
|---|---|---|---|---|---|---|
| 2014 | From Vegas to Macau | Wong Jing | $95,900,000 (China and international) | [10] | ||
| 2014 | The White Haired Witch of Lunar Kingdom | Jacob Cheung | $64,200,000 (China and international) | [10] | ||
| 2014 | The Taking of Tiger Mountain | Tsui Hark | $141,248,984 (China and United States) | [11] | ||
| 2015 | From Vegas to Macau II | Wong Jing | $156,850,000 (China) | [12] | ||
| 2016 | Operation Mekong | Dante Lam | $170,482,937 (China) | [13] | ||
| 2015 | Sword Master | Derek Yee | [12] | |||
| 2015 | Bride Wars | Tony Chan | [14] | |||
| 2015 | Secret Treasure | Ronald Cheng, Gordon Chan | [12] | |||
| 2016 | Billy Lynn's Long Halftime Walk | Ang Lee | TriStar Pictures Studio 8 LStar Capital Film4 Productions The Ink Factory Marc Platt Productions TriStar Productions |
Sony Pictures Releasing | [12] | |
| 2016 | Phantom of the Theatre | Raymond Yip | ||||
| 2017 | Paradox Kill Zone Bangkok | Wilson Yip | [12] | |||
| 2018 | Operation Red Sea | Dante Lam | [15] | |||
| 2019 | A Dog's Way Home | Charles Martin Smith | Columbia Pictures Pariah Productions |
Sony Pictures Releasing | [12] | |
| 2019 | Once Upon a Time in Hollywood | Quentin Tarantino | Columbia Pictures Heyday Films |
Sony Pictures Releasing | [16] | |
| 2019 | Ad Astra | James Gray | Regency Enterprises Plan B Entertainment RT Features Keep Your Head Productions MadRiver Pictures |
20th Century Fox | ||
| 2019 | Midway | Roland Emmerich | Summit Entertainment Centropolis Entertainment RuYi Media Starlight Culture Entertainment Group Street Entertainment AGC Studios Entertainment One |
Lionsgate | ||
| 2020 | Bloodshot | David S.F. Wilson | Columbia Pictures Cross Creek Pictures Original Film Valiant Comics Annabell Pictures The Hideaway Entertainment |
Sony Pictures Releasing | ||
| 2020 | Enter the Fat Dragon | Kenji Tanigaki and Wong Jing | Mega-Vision Pictures (MVP) | |||
| 2021 | The Battle at Lake Changjin | Chen Kaige Tsui Hark Dante Lam |
August First Film Studio Huaxia Film Distribution China Film Co. Ltd. Shanghai Film Group Alibaba Pictures Beijing Dengfeng International Culture Communications Company |
$909,596,236 (China and international) | ||
| 2022 | The Battle at Lake Changjin II | Chen Kaige Tsui Hark Dante Lam |
August First Film Studio Huaxia Film Distribution China Film Co. Ltd. Shanghai Film Group Alibaba Pictures Beijing Dengfeng International Culture Communications Company |
$626,571,697 (China and international) | ||
| TBA | Operation Leviathan | Dante Lam |
References
[edit]- ^ Polybona Films - About Us
- ^ Landreth, Jonathan (17 November 2010). "China's Bona Film Group Files IPO". The Hollywood Reporter.
- ^ Variety (Asia) Magazine
- ^ Xu Fan (China Daily) (June 18, 2015). "Internet Giants Move From Behind the Camera to Front". english.entgroup.cn. EntGroup Inc. Retrieved June 19, 2015.
- ^ "China Film Industry Report 2014-2015 (In Brief)" (PDF). english.entgroup.cn. EntGroup Inc. Archived from the original (PDF) on October 15, 2015. Retrieved October 15, 2015.
- ^ Patrick Frater (April 9, 2015). "Chinese Media Stocks Stage Major Rally in U.S. and Asian Markets". variety.com. Retrieved April 14, 2015.
- ^ Kevin Ma (May 11, 2015). "Bona reports record results for 2015Q1". Film Business Asia. Archived from the original on May 18, 2015. Retrieved May 11, 2015.
- ^ Patrick Frater (November 4, 2015). "China's Bona Film Invests $235 Million in Fox Movie Slate". Variety. Retrieved November 7, 2015.
- ^ Brzeski, Patrick (December 20, 2016). "Alibaba Pictures, Tencent Lead $360M Funding Round in China's Bona Film Group". The Hollywood Reporter. Retrieved December 21, 2016.
- ^ a b Nancy Tartaglione and David Bloom (January 10, 2015). "'Transformers 4′ Tops 2014's 100 Highest-Grossing International Films – Chart". Deadline Hollywood. Retrieved May 11, 2015.
- ^ "THE TAKING OF TIGER MOUNTAIN". Box Office Mojo. Retrieved May 11, 2015.
- ^ a b c d e f Clifford Coonan (May 7, 2015). "China's Bona Film Group Racks Up Record First-Quarter Earnings". The Hollywood Reporter. Retrieved May 11, 2015.
- ^ "Operation Mekong". Box Office Mojo. Retrieved February 6, 2017.
- ^ Kevin Ma (June 19, 2015). "Bona announces giant slate in Shanghai". Film Business Asia. Retrieved June 19, 2015.
- ^ "Bona Film Seeks Status as Chinese Major Ahead of IPO". variety.com. 6 November 2016. Retrieved 2017-03-04.
- ^ Brzeski, Patrick (January 27, 2019). "China's Bona Film Group to Co-Finance Tarantino's 'Once Upon a Time in Hollywood' (Exclusive)". The Hollywood Reporter. Retrieved January 28, 2019.
External links
[edit]Bona Film Group
View on GrokipediaFounding and Early Development
Establishment and Initial Focus (2003–2009)
Bona Film Group emerged in November 2003 from the merger of Beijing Polybona Film Distribution Co., Ltd.—established in 1999 by Yu Dong as China's first privately owned entity to secure a film distribution license from the State Administration of Radio, Film, and Television—with China Poly Group, a state-owned conglomerate with historical ties to the military.[3] Yu Dong, a Beijing Film Academy graduate with prior experience in the industry, retained leadership as chairman and CEO, steering the company toward leveraging Poly Group's resources for expanded operations in a market then dominated by state entities.[11] The company's initial emphasis was on film distribution, capitalizing on China's gradual opening to imported content amid WTO accession quotas allowing limited foreign releases. In 2003, Bona distributed Pirates of the Caribbean: The Curse of the Black Pearl, achieving box office earnings of 28 million yuan (about $3.4 million), which highlighted its capability in marketing Hollywood blockbusters to domestic audiences.[12] This focus extended to Hong Kong and mainland co-productions, building a portfolio that included titles like The Myth and Initial D by 2005, thereby establishing Bona as an early private-sector bridge between local and international cinema in a regulatory environment favoring ideological alignment over commercial viability.[12] During 2003–2009, Bona prioritized distribution over production, amassing experience with over 120 films by 2010 while navigating censorship and quota restrictions that limited foreign imports to 20 revenue-sharing titles annually.[12] Tentative steps into exhibition began in 2008 with the opening of its inaugural cinema in Beijing's Chaoyang district, followed by two more by late 2009, signaling diversification amid rising domestic theater construction driven by urban growth and policy reforms.[3] This phase solidified Bona's role in commercializing China's film sector, though success depended on state approvals and partnerships rather than unfettered market dynamics.Key Early Productions and Market Entry
Bona Film Group, through its predecessor Polybona Films established in 1999, entered the Chinese film market as the first privately owned domestic company to obtain a film distribution license from the State Administration of Radio, Film, and Television (SARFT).[13] This licensing breakthrough allowed early market penetration amid a state-dominated industry, focusing initially on distributing Hong Kong and foreign films to mainland audiences. Key early distributions included high-profile Hong Kong action films such as Initial D (2005), The Myth (2005) starring Jackie Chan, Dragon Tiger Gate (2006), Protégé (2007), and Confession of Pain (2006), which collectively generated significant box office revenue and built Bona's reputation for handling commercially viable imports.[6] These releases capitalized on the growing demand for pan-Asian cinema, helping Bona secure a foothold before broader industry liberalization. In parallel, Bona began venturing into production and co-production during the mid-2000s, marking its transition from pure distributor to integrated player. Its first mainland-Hong Kong co-production, My Sisters and Brothers (2001), exemplified early efforts to foster cross-regional collaborations.[14] By 2003, a merger with China Poly Group—a conglomerate affiliated with the People's Liberation Army—provided capital and infrastructure for expansion, enabling Bona to invest in original content like Something About Secret (directed by Huang Jianxin), acquired for approximately $173,000 with total investment reaching $730,000, representing one of its inaugural forays into film acquisition and potential production support.[3] This period also saw co-productions such as Flash Point (2007) and groundwork for larger projects like The Warlords (2007), aligning with Bona's strategy of blending distribution profits to fund domestic storytelling. By 2007, Bona had scaled to distributing 14 Chinese films annually, positioning it as the second-largest distributor of domestic titles behind the state-owned China Film Group, with a market share reflecting its aggressive early entry tactics.[2] In early 2007, it became the first private Chinese film company to attract international private equity funding, further solidifying market entry by enhancing financial resources for production pipelines.[6] These milestones underscored Bona's causal reliance on distribution as an entry vector, leveraging regulatory advantages and strategic partnerships to transition toward production dominance in a rapidly commercializing sector.Expansion and Commercial Rise
Growth in the 2010s and Blockbuster Strategy
During the early 2010s, Bona Film Group accelerated its growth following its June 2010 initial public offering on the NASDAQ exchange under ticker BONA, the first for a Chinese film company, which raised funds through the sale of approximately 6.5 million American depositary shares.[15] This capital infusion supported operational expansion amid China's burgeoning film market, with the company reporting a 37.6% revenue increase to US$76.6 million for 2010, though it incurred a net loss of US$13.4 million due to IPO-related costs and investments.[16] Bona captured a 15% share of box office grosses for Chinese-language films that year, driven by distribution of hits like the Hong Kong action film Triple.[17] To vertically integrate, Bona entered cinema exhibition in 2010 by acquiring Beijing Bona International Cineplex Investment & Management Co., Ltd., followed by full ownership of Beijing Bona Starlight Cineplex Management Co., Ltd.[18] [19] Its distribution segment maintained stable profit margins of 36% to 39% from 2007 through 2010, benefiting from China's box office expansion from roughly RMB 6.2 billion in 2009 to over RMB 10 billion by 2010.[20] By planning 16 to 20 releases in 2011, Bona aimed to leverage this momentum, including high-profile titles like Flying Swords of Dragon Gate (2011), which grossed over RMB 600 million domestically.[16] Bona's blockbuster strategy in the 2010s emphasized selective investments in high-budget action and war films with patriotic narratives, aligning with state encouragement for "main-melody" content that promoted national pride and historical events, thereby securing regulatory approvals and broad audience appeal in a censored market.[21] Key examples included The Taking of Tiger Mountain (2014), a 3D adaptation of a revolutionary novel depicting anti-Japanese resistance, which earned approximately US$110 million in China, and Operation Mekong (2016), a thriller based on a real 2011 Mekong River incident involving Chinese police cooperation, grossing over US$172 million globally.[15] This focus yielded a 10% share of China's total box office in 2014, with CN¥3 billion generated from 12 films, positioning Bona as the fourth-largest player by revenue.[6] The strategy extended to international diversification, exemplified by a November 2015 US$235 million investment in TSG Entertainment for stakes in Hollywood tentpoles like Avatar sequels, while domestic hits sustained momentum—Q1 2015 alone delivered US$257 million in box office and US$117.6 million in revenue.[2] [22] By prioritizing scalable, event-driven blockbusters over mid-tier releases, Bona mitigated risks in a market favoring nationalism-driven spectacles, contributing to cumulative grosses exceeding RMB 30 billion across its portfolio by the decade's end.[15]International Partnerships and Hollywood Investments
In the early 2010s, Bona Film Group pursued co-production opportunities with Hollywood studios to facilitate access to international markets and content. In April 2012, the company engaged in discussions with multiple U.S. studios regarding joint projects tailored for Chinese audiences, aiming for two such films annually under China's regulatory framework for foreign imports.[23][24] A landmark investment occurred in November 2015, when Bona committed $235 million to TSG Entertainment Finance, securing stakes in a slate of six 20th Century Fox films, including Independence Day: Resurgence, Assassin's Creed, Alien: Covenant, The Martian, X-Men: Apocalypse, and War for the Planet of the Apes. This deal represented one of the largest Chinese investments in Hollywood at the time, driven by Bona's strategy to diversify revenue through global blockbusters amid China's box office growth.[25] In May 2017, Bona partnered with Creative Artists Agency (CAA) to establish a $150 million film fund, co-managed by both entities, targeting English-language productions, Sino-U.S. co-productions, and Chinese-language films.[9] The fund aimed to leverage CAA's talent representation for cross-border financing, though specific project outcomes remained limited in public disclosures. Bona continued selective investments in individual Hollywood titles, acquiring international distribution rights (excluding the U.S.) to Roland Emmerich's Midway in May 2017 from AGC Studios and The Mark Gordon Company.[26] It also invested in films such as James Gray's Ad Astra from New Regency and Quentin Tarantino's Once Upon a Time in Hollywood.[27][7] More recently, in January 2024, Bona announced investments in upcoming installments of the Avatar and Deadpool franchises through a financing arrangement with producer Chip Seelig, building on prior slate deals to tap into established IP for Chinese theatrical releases.[28] These moves reflect Bona's ongoing emphasis on high-grossing franchises, despite regulatory hurdles and geopolitical tensions affecting Sino-Hollywood ties. Complementing production investments, Bona expanded its exhibition partnerships internationally, notably with IMAX Corporation. The alliance, initiated in 2012, grew through multiple agreements, culminating in an April 2024 deal adding three new IMAX theaters in China, bringing the total to 36 locations operated by Bona.[29] This collaboration enhanced Bona's premium screening capabilities for Hollywood imports.[30]Business Model and Operations
Film Production and Distribution Practices
Bona Film Group operates a vertically integrated model encompassing film production, distribution, and exhibition, enabling control over multiple stages of the value chain to mitigate risks and maximize revenue. In production, the company invests heavily in high-budget blockbusters, particularly "Main Melody" films with nationalist themes that align with Chinese regulatory preferences, such as Operation Red Sea (2018, grossing approximately $579 million) and the Changjin Lake series (2021–2022, exceeding $1.3 billion combined). These projects often leverage sequels or prequels for established audiences, with financing through dedicated funds like the RMB 1.0 billion First Film Fund launched in August 2013 and the RMB 1.7 billion Second Film Fund in March 2015. Production requires prior script approval from the State Administration of Press, Publication, Radio, Film and Television (SAPPRFT, now National Radio and Television Administration), followed by a Film Production License subject to biennial inspections; content sensitive to national security demands additional provincial-level clearance. Risks include budget overruns and delays from creative disputes or external factors, exacerbated by shifts to costlier 3D formats.[19][31][32] Distribution practices emphasize broad theatrical reach across virtually all Chinese theater circuits, pioneered by Bona as the first private entity to secure a nationwide Film Distribution License in 2003, overhauling the prior state-dominated system reliant on physical film copies. The company shifted to profit-sharing models from fixed buys, introducing innovations like minimum guarantees, midnight premieres, and daily box-office transparency reporting to build exhibitor trust and optimize revenue splits. By 2014, Bona distributed 13–18 films annually, with top performers (e.g., five films generating 61.2% of that year's net revenue) timed for peak seasons like Lunar New Year; non-theatrical channels, including TV, digital, and home video, supplement income, while international efforts target Asia and North America via acquisitions like China Lion Entertainment (2011) for U.S./Canada releases. A Film Public Screening License is mandatory for all releases, enforcing censorship compliance, and joint ventures with state entities like China Film Group expand access to premium slots. This integration with owned cinemas (118 by 2022, including 96 directly managed) ensures preferential screening but exposes the model to domestic quotas limiting foreign films to 34 annually.[19][3][33] Strategic partnerships underpin both segments, including co-productions with Hong Kong studios since the late 2000s and Hollywood investments (e.g., in The Martian and X-Men: Apocalypse), though cultural and regulatory hurdles—such as profit repatriation delays without co-production treaties—persist. Under China Poly Group's oversight since 2003, practices prioritize commercial viability within state guidelines, fostering high returns on patriotic content amid competition from state-owned distributors, yet narrow genre focus has drawn criticism for limiting diversification, contributing to losses like RMB 72.1 million in 2022 amid pandemic disruptions.[3][32][31]Cinema Chain Management and Diversification
Bona Film Group entered the cinema exhibition sector in 2011 through the acquisition of Beijing Bona Starlight Cineplex Management Co. for approximately 31 million USD, marking a strategic expansion beyond film production and distribution to integrate theater operations into its business model.[34] This move supplemented its core activities by enabling direct control over screening venues, potentially stabilizing revenue streams amid fluctuating box office performance.[35] By the end of 2015, the company owned and operated 30 theaters with 250 screens, including six DMAX and three IMAX screens.[36] Expansion continued, reaching 41 theaters and 336 screens by January 2017.[37] As of December 31, 2021, Bona managed 101 cinemas across China, reflecting sustained investment in circuit management and theater development.[38] To enhance premium viewing options, Bona partnered with IMAX in 2012, committing to 30 new IMAX theaters by 2022 and expanding to a total of 36 IMAX locations by April 2024 through additional agreements for three new sites.[37][39] This collaboration focused on installing advanced screens in multiplexes nationwide, aligning with Bona's emphasis on high-end exhibition to attract audiences for its blockbuster releases. Diversification into cinema chains formed part of Bona's broader integration of the film value chain, redirecting capital from production risks toward exhibition assets for diversified revenue, including ticket sales and advertising.[3] Operations encompass cinema investment, line management, and theater exhibition, contributing to a model that mitigates dependency on content performance alone.[1]Major Productions and Achievements
Patriotic and Action Blockbusters
Bona Film Group has produced several high-budget action blockbusters emphasizing patriotic themes, particularly those glorifying Chinese military operations, disaster response, and historical victories, which have collectively generated substantial box office revenue in China. These films often incorporate advanced visual effects, large-scale battle sequences, and narratives portraying Chinese forces as resolute defenders of national interests, contributing to Bona's reputation for commercially viable titles that resonate with domestic audiences during holiday periods. In 2019 alone, the company released multiple such productions, including firefighter drama The Bravest, which dramatized real-life efforts to contain a chemical plant fire, earning praise for its realistic depictions of heroism amid peril.[40] A cornerstone of this output is Operation Red Sea (2018), directed by Dante Lam and co-produced with entities like Emperor Motion Pictures, depicting People's Liberation Army Navy commandos executing a hostage rescue in a fictional war-torn nation inspired by the 2015 Yemeni crisis. With an investment of approximately $78 million, the film featured intense combat scenes filmed across multiple locations, grossing over $350 million domestically and establishing Bona's model for blending spectacle with state-endorsed valorization of modern armed forces.[41][32] This approach extended to historical epics like The Taking of Tiger Mountain (2014), directed by Tsui Hark, which recounts a 1946 People's Liberation Army operation to dismantle a bandit stronghold during the Chinese Civil War, utilizing 3D effects and period action to highlight revolutionary triumph.[42] Bona's most financially dominant entries are the Battle at Lake Changjin series, starting with the 2021 installment co-directed by Chen Kaige, Tsui Hark, and Dante Lam, which fictionalizes the Chinese People's Volunteer Army's role in the Korean War's Changjin Reservoir campaign against U.S. forces. Budgeted at around $200 million—the costliest Chinese production to date—it amassed CNY 5.775 billion ($913 million) worldwide, surpassing previous records and dominating National Day screenings through its portrayal of endurance in subzero conditions and strategic victories.[43][44] The 2022 sequel, The Battle at Lake Changjin II: Water Gate Bridge, continued the narrative with focus on a decisive bridge battle, quickly exceeding $100 million in its opening days and reinforcing Bona's strategy of sequel-driven patriotic franchises that prioritize empirical depictions of wartime logistics and heroism over nuanced geopolitics.[45] These releases, alongside others like the aviation thriller The Captain (2019) on a real 2018 Sichuan Airlines emergency, underscore Bona's pattern of timing releases for peak audience patriotism, yielding aggregate grosses of CNY 9.83 billion from select titles by 2022.[5]Other Significant Films and Box Office Milestones
Bona Film Group has produced and distributed several films outside the patriotic action blockbuster genre, including critically acclaimed dramas and international co-productions. The 2011 drama A Simple Life, directed by Ann Hui and featuring Andy Lau and Deanie Ip, earned five awards at the 31st Hong Kong Film Awards, including Best Picture and Best Actress for Ip, marking a significant achievement in Hong Kong cinema recognition for the company.[46] The film grossed approximately $4.8 million worldwide on a budget of 30 million yuan, demonstrating Bona's capability in supporting character-driven stories with modest commercial returns but high artistic impact.[47] In international collaborations, Bona co-financed Ang Lee's Billy Lynn's Long Halftime Walk (2016), an adaptation of Ben Fountain's novel focusing on a young soldier's experiences. The film opened to $11.7 million in its first weekend in China, ultimately earning about $23 million there, bolstering Bona's revenue from Hollywood partnerships despite the picture's global underperformance.[48][27] Bona also handled distribution for Wong Kar-wai's The Grandmaster (2013) in China, with a 3D re-release in January 2015 generating $10.13 million in additional box office.[36] Beyond individual titles, Bona has reached key box office milestones, including cumulative ticket sales exceeding 60 billion yuan across its portfolio as of 2022, with 16 films grossing over 1 billion yuan each and 75 surpassing 100 million yuan.[38] In the first quarter of 2015, the company reported a box office gross of $257 million, reflecting strong distribution performance amid China's expanding market.[6] These figures underscore Bona's diversification into varied genres and foreign imports, contributing to its overall market position without relying solely on high-budget spectacles.Financial Performance and Market Position
Revenue Growth and Box Office Dominance
Bona Film Group experienced notable revenue expansion during the mid-2010s, fueled by blockbuster distributions and a burgeoning domestic market. For the nine months ended September 2014, net revenues reached $202 million, supported by high-performing releases that boosted distribution income.[49] Full-year 2014 results showed further gains, with fourth-quarter net revenues of $52.6 million, a 23% increase from the prior year, and annual net income doubling to $16.9 million.[50] This growth trajectory reflected Bona's strategic focus on high-grossing films, though later years saw volatility amid industry-wide challenges like the COVID-19 pandemic and regulatory shifts, with trailing twelve-month revenue stabilizing around $207 million as of mid-2025.[51] The company's box office achievements have cemented its dominance in China's patriotic and action genres, with cumulative grosses exceeding 60 billion CNY as of 2022 across its portfolio.[38] Sixteen films surpassed 1 billion CNY each, including standout war epics that captured massive audience shares during national holidays. The Battle at Lake Changjin (2021), co-produced by Bona, grossed 5.775 billion CNY domestically, becoming China's highest-grossing film to date and the top global earner that year at approximately $892 million.[52][53] Its sequel, The Battle at Lake Changjin II (2022), added over $626 million, dominating the post-Lunar New Year period and highlighting Bona's prowess in state-aligned blockbusters.[54] Other hits like Chinese Doctors (2021) contributed $197 million, reinforcing Bona's market leadership in revenue-generating spectacles.[55]| Key Bona Film Group Box Office Milestones |
|---|
| Film |
| The Battle at Lake Changjin |
| The Battle at Lake Changjin II |
| Chinese Doctors |
